Wendy Ankrom

发表

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants

Jialin Xu, R. Boinpally, M. Dockendorf, 2020, Journal of clinical pharmacology.

A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females

Saijuan Zhang, S. Stoch, M. Iwamoto, 2021, Journal of the International AIDS Society.

Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males

W. Kraft, C. Matthews, J. Wagner, 2020, Clinical and translational science.

Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week

M. Däumer, Saijuan Zhang, J. Hofmann, 2021, Journal of acquired immune deficiency syndromes.

The effect of multiple doses of ubrogepant on the pharmacokinetics of an oral contraceptive in healthy women: Results of an open-label, single-center, two-period, fixed-sequence study

Jialin Xu, J. Palcza, Chi-Chung Li, 2020 .

Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target

Manash S. Chatterjee, Kung-I Feng, J. Metzger, 2016, Pharmacology research & perspectives.

Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir

K. Yee, R. Sanchez, S. Stoch, 2019, Antimicrobial Agents and Chemotherapy.

Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trials

A. Periclou, R. Boinpally, M. Butler, 2021, Cephalalgia Reports.

Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV

R. Mogg, Yang Liu, D. Panebianco, 2021, Clinical and translational science.

Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics

R. Preston, T. Marbury, K. Yee, 2018, Antimicrobial Agents and Chemotherapy.

Characterizing Class‐Specific Exposure‐Viral Load Suppression Response of HIV Antiretrovirals Using A Model‐Based Meta‐Analysis

M. Lai, J. Gobburu, M. Rizk, 2016, Clinical and translational science.